MiLaboratories
MiXCR: Leading NGS data analysis software for immune profiling, empowering R&D in vaccine development & more.
Founded
2021MiXCR: Leading NGS data analysis software for immune profiling, empowering R&D in vaccine development & more.
MiLaboratories, founded with a mission to advance computational biology, focuses on providing cutting-edge software solutions for the analysis of Next-Generation Sequencing (NGS) data. Their flagship product, MiXCR, is a leading platform for immune profiling, widely utilized in vaccine development, CAR-T therapies, and antibody discovery. MiLaboratories serves a diverse market that includes both academic institutions and the pharmaceutical industry, offering MiXCR for free to non-profit researchers to support scientific advancement.
Notable affiliations include partnerships with 8 out of the top 10 Big Pharma companies, underscoring the platform's industry trust and reliability. Key achievements include MiXCR's recognition as the premier solution for immune system studies in both academia and industry. The impact of MiLaboratories is significant, driving forward research and development in critical areas of healthcare and immunology, thereby contributing to the broader scientific community's efforts in combating diseases.
Companies similar to MiLaboratories include Maverix Biomics, Analytica Biosciences, Dotmatics and BioTuring.
MiLaboratories was founded in 2021.
MiLaboratories' headquarters is located in Sunnyvale, CA, US.
MiLaboratories' most recent funding round was for $2.4M (USD) in February 2022.
As of Feb 17, 2022, MiLaboratories has disclosed funding of $2.4M (USD). Undisclosed round amounts are excluded.
MiLaboratories has 14 employees as of Feb 5, 2024.
BioTuring
bioturing.com
